Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
Abstract Respiratory syncytial virus (RSV) is the primary cause of serious lower respiratory tract disease in infants, young children, the elderly and immunocompromised individuals. Therapy for RSV infections is limited to high risk infants and there are no safe and efficacious vaccines. Matrix (M)...
Guardado en:
Autores principales: | Cynthia Mathew, Sharon Tamir, Ralph A. Tripp, Reena Ghildyal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/010a40d4f4ac4e098a1bb5e948447db9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
por: Brian M. Maas, et al.
Publicado: (2021) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunción Mejías, et al.
Publicado: (2008) -
Factors Associated with Severe Lower Respiratory Tract Infection from Respiratory Syncytial Virus (RSV) in Thai Children
por: Atipotsawee Tungsupreechameth, et al.
Publicado: (2021) -
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
por: Marta Gargantilla, et al.
Publicado: (2021) -
Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.
por: Lucas A Vianna, et al.
Publicado: (2021)